Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays
- PMID: 18432938
- DOI: 10.1002/0471142735.im1211s64
Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays
Abstract
Neutralizing antibody assays are powerful tools for assessing humoral immunity in AIDS virus infection and vaccine development. Although many different assays have been described, all are based on the same principle, measuring reductions in virus infectivity. This unit describes two assays utilizing a genetically engineered cell lines that are susceptible to infection by most strains of HIV-1, SIV, and SHIV. One assay is designed for optimal performance with uncloned viruses produced in either PBMC or CD4+ T cell lines. A second assay is designed for single-cycle infection with molecularly cloned pseudoviruses produced by transfection in 293T cells. Both assays are performed in a 96-well format and use tat-responsive luciferase reporter gene expression as readout.
Similar articles
-
Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.J Virol. 1997 Mar;71(3):1911-21. doi: 10.1128/JVI.71.3.1911-1921.1997. J Virol. 1997. PMID: 9032322 Free PMC article.
-
Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.Virology. 2002 Sep 30;301(2):189-205. doi: 10.1006/viro.2002.1544. Virology. 2002. PMID: 12359422
-
Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.AIDS Res Hum Retroviruses. 1997 Jul 20;13(11):913-22. doi: 10.1089/aid.1997.13.913. AIDS Res Hum Retroviruses. 1997. PMID: 9223407
-
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.Virology. 2008 Jun 5;375(2):315-20. doi: 10.1016/j.virol.2008.02.007. Epub 2008 Mar 25. Virology. 2008. PMID: 18367229 Review.
-
Humoral immunity to HIV, SIV, and SHIV.AIDS. 1998;12 Suppl A:S121-32. AIDS. 1998. PMID: 9632993 Review. No abstract available.
Cited by
-
Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells.Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18719-18728. doi: 10.1073/pnas.2010320117. Epub 2020 Jul 20. Proc Natl Acad Sci U S A. 2020. PMID: 32690692 Free PMC article.
-
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody.Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6049-54. doi: 10.1073/pnas.1303682110. Epub 2013 Mar 22. Proc Natl Acad Sci U S A. 2013. PMID: 23524883 Free PMC article.
-
Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.J Infect Dis. 2016 Aug 1;214(3):403-7. doi: 10.1093/infdis/jiw172. Epub 2016 Apr 30. J Infect Dis. 2016. PMID: 27132284 Free PMC article.
-
Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques.J Immunol. 2015 Aug 1;195(3):994-1005. doi: 10.4049/jimmunol.1500083. Epub 2015 Jun 26. J Immunol. 2015. PMID: 26116502 Free PMC article.
-
DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.Hum Vaccin Immunother. 2012 Nov 1;8(11):1630-7. doi: 10.4161/hv.21648. Epub 2012 Oct 30. Hum Vaccin Immunother. 2012. PMID: 23111170 Free PMC article.
References
Literature Cited
-
- Berger, E.A., Murphy, P.M., and Farber, J.M. 1999. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
-
- Brandt, S.M., Mariani, R., Holland, A.U., Hope, T.J., and Landau, N.R. 2002. Association of chemokine-mediated block to HIV entry with coreceptor internalization. J. Biol. Chem. 277:17921-19299.
-
- Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K., Tartaglia, J., Caudrelier, P., Habib, R.E.L., Klein, M., Lazzarin, A., Stablein, D., Deers, M., Corey, L., Greenberg, M.L., Schwartz, D.H., and Montefiori, D.C. 2000. Immunization with recombinant canarypox vectors expressing membrane-anchored gp120 followed by gp160 protein boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 16:2019-2035.
-
- Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N., Gerard, N., Gerard, C., and Sodroski, J. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
-
- Hanson, C.V., Crawford-Miksza, L., and Sheppard, H.W. 1990. Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers. J. Clin. Microbiol. 28:2030-2034.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials